Concepedia

Ingrid B.J. Joseph

IB

Statistics

Publications

31

Citations

2.7K

H-Index

24

Active since

1991

Affiliations

Biogen (United States)(Current)

Johns Hopkins Medicine

Johns Hopkins University

Astellas Pharma (Japan)

University of Santa Monica

Ingrid B.J. Joseph is an author at Biogen (United States) specializing in oncology, medicine, and pharmacology.

ORCID

Publications per year

1991–2024

31

Publications

31

Enfortumab Vedotin Antibody–Drug Conjugate Targeting Nectin-4 Is a Highly Potent Therapeutic Agent in Multiple Preclinical Cancer Models

Pia M. Challita-Eid, Daulet Satpayev, Peng Yang et al. · Cancer Research · 2016 · 696 citations

, , +17

Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissue.

Ingrid B.J. Joseph, Joel B. Nelson, Samuel R. Denmeade et al. · PubMed · 1997 · 213 citations

, , +15

Macrophage Role in the Anti-Prostate Cancer Response to One Class of Antiangiogenic Agents

Ingrid B.J. Joseph, John T. Isaacs · JNCI Journal of the National Cancer Institute · 1998 · 120 citations · Full text

, , +17

An engineered IL-2 reprogrammed for anti-tumor therapy using a semi-synthetic organism

Jerod L. Ptacin, Carolina E. Caffaro, Lina Ma et al. · Nature Communications · 2021 · 120 citations · Full text

, , +17

In Vitro and In Vivo Evaluation of Cysteine and Site Specific Conjugated Herceptin Antibody-Drug Conjugates

Dowdy Jackson, John Atkinson, Claudia Guevara et al. · PLoS ONE · 2014 · 119 citations · Full text

, , +17

1–5 of 31